Published by Josh White on 6th March 2023
(Sharecast News) - Biotechnology developer Sareum announced on Monday that GSK subsidiary Sierra Oncology has returned clinical study reports and associated documents related to 'SRA737' to Sareum's co-development partner, the CRT Pioneer Fund.
URL: http://www.digitallook.com/dl/news/story/33348586/...